Coagulation abnormalities in patients with inoperable lung cancer.
D000368:Aged; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000150:complications*; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis; D006469:Hemoptysis / Q000150:complications; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000150:complications; D008175:Lung Neoplasms / Q000097:blood* / Q000150:complications; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D011517:Prothrombin Time; D013917:Thrombin / Q000032:analysis; D013924:Thrombophlebitis / Q000150:complications; D013925:Thromboplastin / Q000032:analysis
D005340:Fibrinogen; D010958:Plasminogen; D013925:Thromboplastin; D013917:Thrombin; D005341:Fibrinolysin